This item comprised:
| XLS |
|
|
|
|
|
|
|
|
|
€ million |
current |
non-current |
Dec. 31, 2012 |
current |
non-current |
Dec. 31, 2011 |
|
Other financial liabilities |
520.1 |
2.8 |
522.9 |
529.1 |
3.8 |
532.9 |
|
Liabilities from derivatives (operational) |
12.2 |
2.8 |
15.0 |
64.5 |
36.6 |
101.1 |
|
Financial items |
532.3 |
5.6 |
537.9 |
593.6 |
40.4 |
634.0 |
|
Accruals for personnel expenses |
466.2 |
– |
466.2 |
425.6 |
– |
425.6 |
|
Deferred income |
29.5 |
2.6 |
32.1 |
24.2 |
1.6 |
25.8 |
|
Advance payments received from customers |
10.1 |
0.1 |
10.2 |
9.8 |
0.1 |
9.9 |
|
Liabilities from non-income related taxes |
58.1 |
1.1 |
59.2 |
48.9 |
1.5 |
50.4 |
|
Non-financial items |
563.9 |
3.8 |
567.7 |
508.5 |
3.2 |
511.7 |
|
|
1,096.2 |
9.4 |
1,105.6 |
1,102.1 |
43.6 |
1,145.7 |
As of December 31, 2012, other financial liabilities included liabilities due to related companies amounting to € 295.4 million (2011: € 319.3 million). These are profit entitlements of E. Merck KG. Moreover, this item contained liabilities due to affiliates amounting to € 3.6 million (2011: € 0.6 million), interest accruals of € 93.0 million (2011: € 104.2 million) as well as payroll liabilities of € 64.8 million (2011. € 65.5 million). The remaining amount of € 66.1 million (2011: € 43.3 million) recorded under other financial liabilities included employee loans, liabilities due to insurers as well as contractually agreed payment obligations vis-à-vis other companies.